Both BCL-2 and MCL-1 share P2 as a common hot spot region and could be targeted by 2 novel compounds, IS20 and IS21, which induce apoptosis in melanoma and NSCLC cell lines. This evidence concerns the gene MCL1 and non-small cell lung carcinoma.